4DMedical Ltd ( (AU:4DX) ) has shared an update.
4DMedical Limited has successfully completed an oversubscribed Securities Purchase Plan (SPP), raising $8.4 million, which, combined with a previous $5.5 million Placement, totals $13.9 million. These funds will support the company’s efforts to commercialize its lung diagnostics portfolio and advance the FDA submission of its CT:VQ™ technology. The capital raised positions 4DMedical to enhance its market presence and continue developing innovative respiratory diagnostic tools, benefiting shareholders and the broader healthcare industry.
More about 4DMedical Ltd
4DMedical Limited (ASX:4DX) is a global medical technology company specializing in advanced respiratory imaging solutions. The company leverages cutting-edge imaging and AI-powered technologies to provide detailed insights into lung function, facilitating earlier and more accurate diagnoses of respiratory diseases.
YTD Price Performance: -25.00%
Average Trading Volume: 927,646
Technical Sentiment Signal: Buy
Current Market Cap: A$153.7M
For detailed information about 4DX stock, go to TipRanks’ Stock Analysis page.